Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1970 2
1971 3
1972 2
1973 3
1974 2
1975 2
1976 2
1977 1
1978 3
1979 3
1980 1
1981 2
1982 1
1983 4
1984 1
1985 4
1987 7
1988 9
1989 8
1990 19
1991 14
1992 20
1993 26
1994 23
1995 32
1996 45
1997 50
1998 29
1999 25
2000 43
2001 39
2002 18
2003 36
2004 41
2005 40
2006 60
2007 45
2008 45
2009 52
2010 61
2011 53
2012 69
2013 81
2014 66
2015 66
2016 57
2017 55
2018 44
2019 36
2020 60
2021 59
2022 55
2023 52
2024 55
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,511 results

Results by year

Filters applied: . Clear all
Page 1
Thyroid Cancer: A Review.
Boucai L, Zafereo M, Cabanillas ME. Boucai L, et al. JAMA. 2024 Feb 6;331(5):425-435. doi: 10.1001/jama.2023.26348. JAMA. 2024. PMID: 38319329 Review.
IMPORTANCE: Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%. ...Targeted therapies such as dabrafenib and selpercatinib are directed to genetic mutations (BRAF, RE …
IMPORTANCE: Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. Five-year rela …
Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O. Baloch ZW, et al. Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14. Endocr Pathol. 2022. PMID: 35288841 Review.
Follicular cell-derived tumors constitute the majority of thyroid neoplasms. In this new classification, they are divided into benign, low-risk, and malignant neoplasms. ...Anaplastic thyroid carcinoma remains the most undifferentiated form; squ …
Follicular cell-derived tumors constitute the majority of thyroid neoplasms. In this new classification, they are divided into …
Management of medullary carcinoma of the thyroid: a review.
Jayasinghe R, Basnayake O, Jayarajah U, Seneviratne S. Jayasinghe R, et al. J Int Med Res. 2022 Jul;50(7):3000605221110698. doi: 10.1177/03000605221110698. J Int Med Res. 2022. PMID: 35822284 Free PMC article. Review.
Medullary thyroid carcinoma (MTC) is an uncommon malignancy of neuroendocrine origin derived from the parafollicular C cells. ...
Medullary thyroid carcinoma (MTC) is an uncommon malignancy of neuroendocrine origin derived from the parafollicular C …
Thyroid cancer.
Cabanillas ME, McFadden DG, Durante C. Cabanillas ME, et al. Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27. Lancet. 2016. PMID: 27240885 Review.
Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers hav …
Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with expe …
Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D. Thomas CM, et al. Curr Oncol. 2019 Oct;26(5):338-344. doi: 10.3747/co.26.5539. Epub 2019 Oct 1. Curr Oncol. 2019. PMID: 31708652 Free PMC article. Review.
BACKGROUND: Medullary thyroid carcinoma (mtc) is a rare malignancy of the thyroid gland, and raising awareness of the recommended diagnostic workup and pathologic characteristics of this malignancy is therefore important. ...SUMMARY: Although the initi …
BACKGROUND: Medullary thyroid carcinoma (mtc) is a rare malignancy of the thyroid gland, and raising awareness o …
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Jung CK, Bychkov A, Kakudo K. Jung CK, et al. Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4. Endocrinol Metab (Seoul). 2022. PMID: 36193717 Free PMC article. Review.
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a grading system. ...The terms "follicular nodular disease" and "differentiated high-grade …
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 inclu …
Updates on the Management of Thyroid Cancer.
Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Araque KA, et al. Horm Metab Res. 2020 Aug;52(8):562-577. doi: 10.1055/a-1089-7870. Epub 2020 Feb 10. Horm Metab Res. 2020. PMID: 32040962 Free PMC article. Review.
The diagnostic modalities, stratification tools, and treatment options for patients with thyroid cancer have rapidly evolved since the development of the American Thyroid Association (ATA) guidelines in 2015. This review compiles newer concepts in diagnosis, stratif …
The diagnostic modalities, stratification tools, and treatment options for patients with thyroid cancer have rapidly evolved since th …
Current Guidelines for Management of Medullary Thyroid Carcinoma.
Kim M, Kim BH. Kim M, et al. Endocrinol Metab (Seoul). 2021 Jun;36(3):514-524. doi: 10.3803/EnM.2021.1082. Epub 2021 Jun 22. Endocrinol Metab (Seoul). 2021. PMID: 34154310 Free PMC article. Review.
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnostic and therapeutic strategies for the condition are different from those used for well-differentiated thyroid cancer. Since the 2015 …
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnos …
Medullary thyroid carcinoma.
Pelizzo MR, Mazza EI, Mian C, Merante Boschin I. Pelizzo MR, et al. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(9):943-957. doi: 10.1080/14737140.2023.2247566. Epub 2023 Aug 30. Expert Rev Anticancer Ther. 2023. PMID: 37646181 Free article. Review.
INTRODUCTION: Medullary thyroid carcinoma (MTC) constitutes approximately 5-10% of all thyroid cancers. Although the tumor forms in the thyroid, it doesn't originate from thyroid cells, but from the C cells or parafollicular cells which p …
INTRODUCTION: Medullary thyroid carcinoma (MTC) constitutes approximately 5-10% of all thyroid cancers. Although …
Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities.
Zhang L, Feng Q, Wang J, Tan Z, Li Q, Ge M. Zhang L, et al. Biochim Biophys Acta Rev Cancer. 2023 Jul;1878(4):188928. doi: 10.1016/j.bbcan.2023.188928. Epub 2023 May 29. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37257629 Free article. Review.
However, recurrence or tumor metastasis remains the main challenge in the management of anaplastic thyroid cancer (ATC) and radioiodine (RAI) radioactive iodine-refractory differentiated thyroid cancer (RR-DTC). Several multi-tyrosine kinase inhibitors (MKIs), or im …
However, recurrence or tumor metastasis remains the main challenge in the management of anaplastic thyroid cancer (ATC) and radioiodi …
1,511 results